Not only that, but the soluble ACE2 can also convert angiotensin II to angiotensin 1–7, and therefore, it can decrease the cardiovascular complications associated with the high level of angiotensin II in severe or critically ill cases of COVID-19 [225]. This evidence concerns the gene ACE2 and COVID-19.